{
  "report_rows": [
    {
      "kpi": "Organic Sales Growth (Q2 2026)",
      "prediction": "MISS",
      "answer": "pred ~+1.8% vs. cons +2.47%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adj. EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$0.325 vs. cons $0.313",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adj. Gross Margin (Q2 2026)",
      "prediction": "IN-LINE",
      "answer": "pred ~61.2% vs. cons ~61.0%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Organic trajectory / 2H tone (qualitative, FY2026)",
      "prediction": "LOWER",
      "answer": "guide measured/cautious; implies 2H organic below ~+2.5-3% embedded in FY cons",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "KMB merger close (qualitative)",
      "prediction": "UNCHANGED",
      "answer": "guide reaffirm on track for 2H 2026 close",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": -2.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -3.0,
  "day5_path": "FADE",
  "day5_rationale": "FADE \u2014 organic miss drives modest sell-side revenue cuts; EPS beat provides floor but does not offset implicit forward cut signal",
  "day5_confidence": "MEDIUM"
}